INS and Hypoglycemia: Supplementary data showed that, except for 24 h CGM, hypoglycemia, and severe hypoglycemia, the P-values of the discordance test for other outcome indicators were all greater than 0.05, and there was no local discordance (Supplementary Data Table S13). For hypoglycemia, there was discordance between placebo + insulin vs dapagliflozin + insulin (p <0.05). For 24 h CGM and severe hypoglycemia, there was no comparison to assess inconsistency. The trace map, density map, and convergence diagnostic diagram for all outcome indicators are shown in the Supplementary Material (Figures S1–S9).